Study finds benefits listed in larger text than risks in mags

Share this article:
A study of oncology drug ads in the magazines CURE, Coping With Cancer and MAMM found benefits presented more prominently and in larger text than risks. The study, presented to the American Society of Clinical Oncology's annual meeting, found that while benefits usually placed in the top third of the ad space, risks were often presented in smaller type and relegated to the lower half of the page.
Share this article:
You must be a registered member of MMM to post a comment.

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.